Have a personal or library account? Click to login
A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort Cover

A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort

Radiology and Oncology
Volume 53 (2019): Issue 2 (June 2019)
By: Stefan Janssen,  Heinke C Hansen,  Liesa Dziggel,  Steven E Schild and  Dirk Rades  
Open Access
|May 2019

Authors

Stefan Janssen

Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany

Heinke C Hansen

Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany

Liesa Dziggel

Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany

Steven E Schild

Department of Radiation Oncology, Mayo Clinic Scottsdale, Arizona, U.S.A.

Dirk Rades

dirk.rades@uksh.de

Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
DOI: https://doi.org/10.2478/raon-2019-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 219 - 224
Submitted on: Feb 12, 2019
|
Accepted on: Mar 27, 2019
|
Published on: May 8, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
breast cancer,
cerebral metastases,
whole-brain radiotherapy,
overall survival time,
diagnosis-specific predictive tool
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2019 Stefan Janssen, Heinke C Hansen, Liesa Dziggel, Steven E Schild, Dirk Rades, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 53 (2019): Issue 2 (June 2019)Next article